Cytek Biosciences
CTKB
CTKB
84 hedge funds and large institutions have $568M invested in Cytek Biosciences in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
26
Increased
36
Reduced
17
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
$22.5M |
| 2 |
BlackRock
New York
|
$76.6M |
| 3 |
RI
RTW Investments
New York
|
$9.84M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
$16.5M |
| 5 |
Millennium Management
New York
|
$9.68M |
Top Sellers
| 1 |
MGM
Miura Global Management
New York
|
$17.7M |
| 2 |
Goldman Sachs
New York
|
$803K |
| 3 |
Two Sigma Investments
New York
|
$0 |
| 4 |
D.E. Shaw & Co
New York
|
$2.26M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$279K |
